Moreover, theobserved reduction in inflammatory infiltrates and COX-2 expressionsuggests that this system may modulate the tumor immune microenvironment,potentially improving the efficacy of immune checkpoint inhibitorsor dendritic cell-based vaccines. The gene discussed is PTGS2; the disease is neoplasm.